07:31 AM EDT, 07/29/2025 (MT Newswires) -- Salarius Pharmaceuticals ( SLRX ) shares were 176% higher pre-bell Tuesday following a 1.2% loss in the previous session.

Sarepta Therapeutics ( SRPT ) stock was up 39% after the company said late Monday that the US Food and Drug Administration has recommended the removal of the company's voluntary pause on shipments of Duchenne muscular dystrophy treatment Elevidys.

GeneDx ( WGS ) shares were 27% higher after the company reported it swung to Q2 adjusted earnings amid higher revenue and raised its fiscal 2025 revenue outlook.

Chart Industries ( GTLS ) was up 16% after the company posted higher Q2 adjusted earnings and said it would be acquired by Baker Hughes for $210 per share in cash.